Amarin Corp Plcuk (AMRN) Non-Current Assets (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Non-Current Assets of $19.8 million for Q1 2026, down 76.08% year-over-year from $82.6 million in Q1 2025, and down 5.4% quarter-over-quarter from $20.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Non-Current Assets (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Non-Current Assets data on file, last reported at $19.8 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $19.8 million, down 76.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $135.5 million (down 63.49% YoY), and the FY2025 annual result was $20.9 million, down 76.77% from the prior year.
  • Non-Current Assets retreated to $19.8 million in Q1 2026 per AMRN's latest filing, from $20.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $254.1 million in Q2 2022 and troughed at $19.8 million in Q1 2026.
  • A 5-year average of $120.1 million and a median of $102.1 million in 2024 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 418.74% in 2022, then sank 76.77% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $197.1 million in 2022, then plunged by 45.86% to $106.7 million in 2023, then decreased by 15.7% to $90.0 million in 2024, then slumped by 76.77% to $20.9 million in 2025, then decreased by 5.4% to $19.8 million in 2026.
  • Business Quant data shows AMRN's Non-Current Assets at $19.8 million in Q1 2026, $20.9 million in Q4 2025, and $31.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 60.81 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 61.74 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 141.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 102.93 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 125.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 61.03 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 37.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 165.18 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 59.27 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 19.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.76 Mn
Dec 31, 2025 20.89 Mn
Sep 30, 2025 31.51 Mn
Jun 30, 2025 63.33 Mn
Mar 31, 2025 82.64 Mn
Dec 31, 2024 89.95 Mn
Sep 30, 2024 100.40 Mn
Jun 30, 2024 98.10 Mn
Mar 31, 2024 102.11 Mn
Dec 31, 2023 106.70 Mn
Sep 30, 2023 121.52 Mn
Jun 30, 2023 153.52 Mn
Mar 31, 2023 176.39 Mn
Dec 31, 2022 197.08 Mn
Sep 30, 2022 221.78 Mn
Jun 30, 2022 254.14 Mn
Mar 31, 2022 201.09 Mn
Dec 31, 2021 189.34 Mn
Sep 30, 2021 72.77 Mn
Jun 30, 2021 48.99 Mn